5.62
Precedente Chiudi:
$5.42
Aprire:
$5.52
Volume 24 ore:
473.56K
Relative Volume:
0.77
Capitalizzazione di mercato:
$515.68M
Reddito:
$14.02M
Utile/perdita netta:
$-84.03M
Rapporto P/E:
-3.8231
EPS:
-1.47
Flusso di cassa netto:
$-125.54M
1 W Prestazione:
-12.87%
1M Prestazione:
+8.08%
6M Prestazione:
-15.62%
1 anno Prestazione:
+10.85%
Meiragtx Holdings Plc Stock (MGTX) Company Profile
Nome
Meiragtx Holdings Plc
Settore
Industria
Telefono
646-860-7985
Indirizzo
450 EAST 29TH STREET, NEW YORK, NY
Confronta MGTX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
MGTX
Meiragtx Holdings Plc
|
5.62 | 515.68M | 14.02M | -84.03M | -125.54M | -1.47 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
439.37 | 128.45B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
575.63 | 65.17B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ARGX
Argen X Se Adr
|
560.90 | 40.09B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
270.19 | 35.67B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ONC
Beigene Ltd Adr
|
233.25 | 27.44B | 3.81B | -644.79M | -669.77M | -6.24 |
Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-07-31 | Ripresa | Chardan Capital Markets | Buy |
2020-10-23 | Iniziato | RBC Capital Mkts | Outperform |
2020-09-15 | Ripresa | BofA Securities | Buy |
2019-09-03 | Iniziato | Piper Jaffray | Overweight |
2019-02-27 | Reiterato | Chardan Capital Markets | Buy |
2018-07-03 | Iniziato | Barclays | Overweight |
2018-07-03 | Iniziato | BofA/Merrill | Buy |
Mostra tutto
Meiragtx Holdings Plc Borsa (MGTX) Ultime notizie
Wells Fargo & Company MN Has $144,000 Stock Position in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMA - GuruFocus
MeiraGTx (MGTX) Gains RMAT Designation for Parkinson's Treatment - GuruFocus
FDA grants RMAT status to MeiraGTx’s Parkinson’s treatment By Investing.com - Investing.com South Africa
MeiraGTx (MGTX) Gains FDA RMAT Designation for Parkinson's Treat - GuruFocus
MeiraGTx gets FDA RMAT status for its Parkinson’s disease treatment - Seeking Alpha
MeiraGTx (MGTX) Gains FDA RMAT Designation for Parkinson's Treatment | MGTX Stock News - GuruFocus
MeiraGTx Holdings Receives FDA RMAT Designation for AAV-GAD - TipRanks
MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV-GAD for the Treatment of Parkinson's Disease - The Manila Times
FDA grants RMAT status to MeiraGTx’s Parkinson’s treatment - Investing.com
MeiraGTx Holdings Receives RMAT Designation from FDA for AAV-GAD Gene Therapy in Parkinson's Disease - Nasdaq
Invesco Ltd. Increases Stake in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
MeiraGTx Holdings PLC expected to post a loss of 49 cents a shareEarnings Preview - TradingView
MeiraGTx Holdings plc's (NASDAQ:MGTX) Shift From Loss To Profit - simplywall.st
MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Bought by Geode Capital Management LLC - Defense World
Kadmon Announces Sale of 1.4 Million Shares of MeiraGTx Holdings plc - ACCESS Newswire
What is the investor’s view on MeiraGTx Holdings plc (MGTX)? - uspostnews.com
MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Sold by JPMorgan Chase & Co. - Defense World
MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates - ADVFN
MeiraGTx CFO Richard Giroux sells $144,000 in stock By Investing.com - Investing.com India
MeiraGTx CFO Richard Giroux sells $144,000 in stock - Investing.com
Parkinson’s Disease Therapeutic Domain Projected to See Transformational Growth Across the 7MM During the Study Period (2020–2034) | DelveInsight - GlobeNewswire Inc.
Russell Investments Group Ltd. Has $1.72 Million Stake in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
MGTX Stock Update: MeiraGTx Holdings plc’s Banking’s Market Struggles and Potential Opportunities - investchronicle.com
MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Purchased by Corebridge Financial Inc. - Defense World
MeiraGTx CEO Alexandria Forbes sells shares worth $253,650 By Investing.com - Investing.com UK
MeiraGTx CEO Alexandria Forbes sells shares worth $253,650 - Investing.com
(MGTX) Trading Advice - news.stocktradersdaily.com
MeiraGTx Holdings Signs New Lease in New York - TipRanks
MeiraGTx Holdings secures new lease, terminates old sublease - Investing.com Australia
MeiraGTx Holdings secures new lease, terminates old sublease By Investing.com - Investing.com Canada
Is MeiraGTx Holdings (NASDAQ:MGTX) Using Debt Sensibly? - simplywall.st
MeiraGTx Reports Strategic Advances and Financial Results - TipRanks
Charles Schwab Investment Management Inc. Buys 12,961 Shares of MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
Chardan Capital Forecasts MeiraGTx FY2026 Earnings - MarketBeat
Chardan Capital Comments on MeiraGTx FY2026 Earnings - Defense World
MeiraGTx Holdings plc (NASDAQ:MGTX) Stock Position Increased by Bank of New York Mellon Corp - Defense World
Chardan Capital Forecasts MeiraGTx FY2025 Earnings - Defense World
MeiraGTx Holdings: Gaining Regulatory Focus (NASDAQ:MGTX) - Seeking Alpha
MeiraGTx Holdings plc (NASDAQ:MGTX) Is Expected To Breakeven In The Near Future - Yahoo
Reviewing MeiraGTx (NASDAQ:MGTX) and CRISPR Therapeutics (NASDAQ:CRSP) - Defense World
MeiraGTx (NASDAQ:MGTX) Given New $13.00 Price Target at Royal Bank of Canada - Defense World
MeiraGTx Holdings (MGTX) Partners with Hologen for $200M AI-Powered Parkinson’s Treatment - Insider Monkey
RBC Capital raises MeiraGTx stock price target to $13.00 By Investing.com - Investing.com Canada
RBC Capital raises MeiraGTx stock price target to $13.00 - Investing.com
Meiragtx Holdings Plc Azioni (MGTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):